default author photo

Elie Traer

Oregon Health and Science University - OHSU Knight Cancer Center Institute

3181 S.W. Sam Jackson Park Rd.

Portland, OR 97201

United States

SCHOLARLY PAPERS

3

DOWNLOADS

213

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

The AML Microenvironment Catalyzes a Step-Wise Evolution to Gilteritinib Resistance

Number of pages: 94 Posted: 22 Jan 2021
Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Pacific Northwest National Laboratory - Environmental and Molecular Sciences Division, University of Colorado, Aurora - Department of Biochemistry and Molecular Genetics, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, Pacific Northwest National Laboratory - Biological Sciences Division, University of Massachusetts Boston - Computer Science Department, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - Department of Molecular and Medical Genetics, University of Colorado at Denver - Department of Biochemistry and Molecular Genetics, Pacific Northwest National Laboratory - Biological Sciences Division, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Pacific Northwest National Laboratory - Biological Sciences Division, Oregon Health and Science University - OHSU Knight Cancer Center Institute and Oregon Health and Science University - OHSU Knight Cancer Center Institute
Downloads 101 (684,672)

Abstract:

Loading...

AML, FLT3, Tumor Microenvironment, Gilteritinib, Aurora Kinase B, NRAS, Drug Resistance, Tyrosine Kinase Inhibitor, CPTAC

2.

Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia

Number of pages: 57 Posted: 22 Feb 2022
affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, City of Hope, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - Department of Molecular and Medical Genetics, Oregon Health & Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon State University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, University of Florida - Division of Hematology/Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of Colorado Denver, affiliation not provided to SSRN, University of Miami, University of Miami, University of Colorado at Denver - Division of Hematology, University of Utah, University of Miami, University of Kansas Medical Center, Oregon Health and Science University, Oregon Health and Science University and Oregon Health and Science University - Division of Bioinformatics and Computational Biology
Downloads 72 (860,052)

Abstract:

Loading...

hematologic malignancy, targeted therapy, LSC17, cell state, leukemia stem cell, monocyte, eigengene, JEDI, MEGF12

3.

Mapping the Proteogenomic Landscape Enables Prediction of Drug Response in Acute Myeloid Leukemia

Number of pages: 30 Posted: 13 Jun 2023
Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Government of the United States of America - Pacific Northwest National Laboratory, Oregon Health and Science University - Division of Oncological Sciences, Oregon Health and Science University, Government of the United States of America - Pacific Northwest National Laboratory, Oregon Health and Science University, Government of the United States of America - Pacific Northwest National Laboratory, Oregon Health and Science University - Division of Bioinformatics and Computational Biology, Oregon Health and Science University, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Government of the United States of America - Pacific Northwest National Laboratory, Oregon Health and Science University, Government of the United States of America - Pacific Northwest National Laboratory and Government of the United States of America - Earth and Biological Sciences Directorate
Downloads 40 (1,183,237)

Abstract:

Loading...

proteomics, Transcriptomics, genomics, multi-omics, acute myeloid leukemia, non-negative matrix factorization, linear regression, drug response